Prematurity
Poster Session 2
Sofie H. Breuking, MD
Amsterdam UMC, location AMC
Amsterdam, Noord-Holland, Netherlands
Annemijn de Ruigh, MA, MD, MSc, PhD
Amsterdam UMC, location AMC
Amsterdam, Noord-Holland, Netherlands
Carme Merced, MD
Hospital Universitari Vall d'Hebron
Barcelona, Spain, Spain
Laia Pratcorona, MD
Hospital Universitari Vall d'Hebron
Barcelona, Spain, Spain
Madelon van Wely, MSc
Amsterdam Reproduction and Development Research Institute, Amsterdam UMC
Amsterdam, Noord-Holland, Netherlands
Rik van Eekelen, MSc
Amsterdam Reproduction and Development Research Institute, Amsterdam UMC
Amsterdam, Noord-Holland, Netherlands
Elena Carreras, MD, PhD
Hospital Universitari Vall d'Hebron
Barcelona, Spain, Spain
Gabriele Saccone, MD
Università degli studi di Napoli Federico II
PHILADELPHIA, PA, United States
Ben Willem W. Mol, MD, PhD (he/him/his)
Professor of Obstetrics/Gynecology
Monash University
Clayton, Victoria, Australia
Maria Goya, MD, PhD
Hospital Universitari Vall d'Hebron
Barcelona, Spain, Spain
Eva Pajkrt, MD, PhD, Prof. (she/her/hers)
Head of Obstetrics
Amsterdam UMC, location AMC
Amsterdam, Noord-Holland, Netherlands
Frederik J.R. Hermans, MD, PhD
Amsterdam UMC, location AMC
Amsterdam, Noord-Holland, Netherlands
Randomized controlled trials (RCTs) on using a cervical pessary after an episode of preterm labor (PTL) show contradictive results. This study aims to perform an Individual Participant Data Meta-Analysis (IPD-MA) to assess the effectiveness of a cervical pessary to prolong pregnancy after an episode of PTL.
Study Design:
For this IPD-MA, RCTs were included that randomized pregnant women with a singleton pregnancy between 24-34 weeks with an ceased episode of PTL between cervical pessary or control (no intervention). This IPD-MA followed the PRISMA-IPD guidelines. Co-primary outcomes were: interval between randomization and delivery, delivery < 7 days and a composite of neonatal outcomes (mortality and severe morbidity). Secondary outcomes were maternal and neonatal outcomes according to the core outcomes set for preterm birth(PTB) studies. For all outcomes, a one-step meta-analysis approach was employed.
Results:
Five RCTs were eligible for inclusion of which three were included(n=273 pessary group, n=268 control group). Two trials were excluded since no data was provided. Mean prolongation of pregnancy was 59.3±27.7 days for pessary compared to 54.9±27.1 days for controls with a mean difference of 4.5 days (95% CI -0.08 - 9.0; P-value 0.054). Cervical pessary did not reduce risk of delivery < 7 days (RR 0.87; 95% CI 0.40 - 1.9; P-value 0.31). Moreover, there was no reduction in composite neonatal outcome (7.7% versus 8.2%, RR 0.95; 95% CI 0.53 - 1.7). Readmissions for PTL were lower in the pessary group (45 vs. 77, RR 0.50; 95% CI 0.32-0.77). No differences were found for other secondary maternal or perinatal outcomes (Table 1).
Conclusion:
In women who went through an episode of PTL, we found no statistical significant beneficial effect for pessary placement in terms of delivery < 7 days, prolongation of pregnancy, PTB, or neonatal outcomes between both groups. Pessary reduced the probability of readmissions for PTL.